US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 46.120
  • +1.930+4.37%
Close Aug 23 16:00 ET
  • 46.120
  • 0.0000.00%
Post 19:18 ET
2.82BMarket Cap-10602P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
29.24%-29.08M
-11.83%-40.74M
21.49%-136.16M
13.58%-29.38M
37.75%-29.25M
-5.88%-41.09M
32.07%-36.43M
-18.78%-173.43M
15.99%-34M
-17.00%-46.99M
Net income from continuing operations
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
Operating gains losses
-30,766.67%-9.2M
-880.00%-490K
-124.05%-190K
84.00%-40K
---130K
--30K
---50K
100.79%790K
---250K
----
Depreciation and amortization
-11.76%390K
-11.38%405K
5.14%1.76M
-5.66%417K
0.00%442K
0.91%442K
30.57%457K
44.39%1.67M
36.00%442K
40.32%442K
Other non cash items
44.75%5.05M
1,039.58%97.43M
279.30%19.43M
31.79%4.13M
57.37%3.27M
18,447.37%3.49M
13,253.85%8.55M
2,148.80%5.12M
4,915.38%3.13M
3,395.24%2.08M
Change In working capital
59.34%-2.15M
-179.45%-2.19M
127.61%4.81M
305.32%8.91M
89.10%-1.58M
-929.87%-5.28M
147.78%2.75M
-1,017.76%-17.41M
-59.65%2.2M
-817.62%-14.48M
-Change in receivables
49.19%-2.9M
109.09%172K
-66.24%-8.64M
94.72%-178K
-591.94%-858K
-235.13%-5.71M
---1.89M
-315.92%-5.2M
-169.60%-3.37M
---124K
-Change in inventory
-405.36%-3.49M
104.55%117K
-103.39%-5.71M
29.98%-862K
-31,800.00%-1.59M
56.33%-690K
---2.57M
-25,409.09%-2.81M
---1.23M
--5K
-Change in prepaid assets
540.33%2.71M
-212.34%-2.42M
477.51%2.88M
327.17%5.24M
-3,968.32%-3.91M
-135.04%-615K
126.84%2.16M
114.91%498K
53.18%-2.31M
-96.59%101K
-Change in payables and accrued expense
-27.08%482K
-124.21%-1.25M
857.42%14.77M
-69.08%4.86M
132.52%4.09M
142.73%661K
9,849.06%5.17M
-91.57%1.54M
21.61%15.71M
-309.83%-12.57M
-Change in other current assets
-13.75%1.05M
1,307.07%1.2M
134.21%1.66M
-500.00%-4K
161.72%537K
-54.57%1.22M
98.51%-99K
59.04%-4.84M
100.08%1K
91.74%-870K
-Change in other working capital
----
----
97.76%-148K
----
----
---142K
---6K
---6.61M
----
----
Cash from discontinued investing activities
Operating cash flow
29.24%-29.08M
-11.83%-40.74M
21.49%-136.16M
13.58%-29.38M
37.75%-29.25M
-5.88%-41.09M
32.07%-36.43M
-18.78%-173.43M
15.99%-34M
-17.00%-46.99M
Investing cash flow
Cash flow from continuing investing activities
-117.77%-8.56M
62.75%30.05M
-120.21%-5.67M
155.52%22.64M
-139.21%-94.96M
33.94%48.19M
-74.54%18.46M
145.09%28.03M
-662.57%-40.78M
-163.23%-39.7M
Net PPE purchase and sale
--0
--0
83.27%-47K
0.00%1K
98.95%-1K
--0
62.99%-47K
35.25%-281K
101.47%1K
10.38%-95K
Net intangibles purchase and sale
----
----
--0
--0
--5.4M
----
----
-300.00%-4M
--0
--0
Net business purchase and sale
----
----
--0
----
----
----
----
--0
----
----
Net investment purchase and sale
-117.45%-8.56M
204.16%70.05M
-99.85%49K
155.52%22.64M
-139.10%-94.69M
22.55%49.07M
-68.30%23.03M
119.73%32.31M
-13,003.80%-40.78M
-162.97%-39.6M
Net other investing changes
----
-784.96%-40M
---5.67M
--0
----
----
---4.52M
----
----
----
Cash from discontinued investing activities
Investing cash flow
-117.77%-8.56M
62.75%30.05M
-120.21%-5.67M
155.52%22.64M
-139.21%-94.96M
33.94%48.19M
-74.54%18.46M
145.09%28.03M
-662.57%-40.78M
-163.23%-39.7M
Financing cash flow
Cash flow from continuing financing activities
15,248.08%146.18M
3,290.23%4.24M
-65.22%74.37M
-86.05%2.42M
-53.93%73.04M
-102.57%-965K
-133.33%-133K
28.44%213.83M
17,265.00%17.37M
38,293.22%158.56M
Net common stock issuance
----
----
-62.72%48.88M
--0
----
----
----
-18.93%131.11M
282,860.00%14.14M
----
Proceeds from stock option exercised by employees
311.14%1.4M
476.85%7.03M
-17.89%8.52M
-15.15%5M
-51.96%1.97M
--341K
205.26%1.22M
118.25%10.38M
5,508.57%5.89M
890.31%4.09M
Net other financing activities
553.83%5.93M
-106.00%-2.78M
-76.54%16.97M
3.31%-2.57M
-40.79%22.2M
---1.31M
---1.35M
--72.34M
---2.66M
--37.5M
Cash from discontinued financing activities
Financing cash flow
15,248.08%146.18M
3,290.23%4.24M
-65.22%74.37M
-86.05%2.42M
-53.93%73.04M
-102.57%-965K
-133.33%-133K
28.44%213.83M
17,265.00%17.37M
38,293.22%158.56M
Net cash flow
Beginning cash position
-51.01%53.89M
-52.81%60.41M
114.86%128.01M
-64.99%64.92M
2.18%116.01M
39.46%109.99M
114.86%128.01M
-41.16%59.58M
100.02%185.42M
62.97%113.54M
Current changes in cash
1,668.92%108.54M
64.37%-6.45M
-198.58%-67.45M
92.48%-4.32M
-171.19%-51.17M
-82.30%6.14M
-193.85%-18.1M
264.17%68.43M
-73.32%-57.41M
212.07%71.88M
Effect of exchange rate changes
-166.37%-301K
-182.56%-71K
---142K
---192K
--77K
---113K
--86K
--0
--0
--0
End cash Position
39.75%162.13M
-51.01%53.89M
-52.81%60.41M
-52.81%60.41M
-64.99%64.92M
2.18%116.01M
39.46%109.99M
114.86%128.01M
114.86%128.01M
100.02%185.42M
Free cash flow
-48.60%-69.08M
-11.69%-40.74M
23.36%-136.2M
13.58%-29.38M
49.33%-23.86M
-8.43%-46.49M
32.14%-36.48M
-17.35%-177.71M
16.13%-34M
-16.93%-47.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 29.24%-29.08M-11.83%-40.74M21.49%-136.16M13.58%-29.38M37.75%-29.25M-5.88%-41.09M32.07%-36.43M-18.78%-173.43M15.99%-34M-17.00%-46.99M
Net income from continuing operations 30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M
Operating gains losses -30,766.67%-9.2M-880.00%-490K-124.05%-190K84.00%-40K---130K--30K---50K100.79%790K---250K----
Depreciation and amortization -11.76%390K-11.38%405K5.14%1.76M-5.66%417K0.00%442K0.91%442K30.57%457K44.39%1.67M36.00%442K40.32%442K
Other non cash items 44.75%5.05M1,039.58%97.43M279.30%19.43M31.79%4.13M57.37%3.27M18,447.37%3.49M13,253.85%8.55M2,148.80%5.12M4,915.38%3.13M3,395.24%2.08M
Change In working capital 59.34%-2.15M-179.45%-2.19M127.61%4.81M305.32%8.91M89.10%-1.58M-929.87%-5.28M147.78%2.75M-1,017.76%-17.41M-59.65%2.2M-817.62%-14.48M
-Change in receivables 49.19%-2.9M109.09%172K-66.24%-8.64M94.72%-178K-591.94%-858K-235.13%-5.71M---1.89M-315.92%-5.2M-169.60%-3.37M---124K
-Change in inventory -405.36%-3.49M104.55%117K-103.39%-5.71M29.98%-862K-31,800.00%-1.59M56.33%-690K---2.57M-25,409.09%-2.81M---1.23M--5K
-Change in prepaid assets 540.33%2.71M-212.34%-2.42M477.51%2.88M327.17%5.24M-3,968.32%-3.91M-135.04%-615K126.84%2.16M114.91%498K53.18%-2.31M-96.59%101K
-Change in payables and accrued expense -27.08%482K-124.21%-1.25M857.42%14.77M-69.08%4.86M132.52%4.09M142.73%661K9,849.06%5.17M-91.57%1.54M21.61%15.71M-309.83%-12.57M
-Change in other current assets -13.75%1.05M1,307.07%1.2M134.21%1.66M-500.00%-4K161.72%537K-54.57%1.22M98.51%-99K59.04%-4.84M100.08%1K91.74%-870K
-Change in other working capital --------97.76%-148K-----------142K---6K---6.61M--------
Cash from discontinued investing activities
Operating cash flow 29.24%-29.08M-11.83%-40.74M21.49%-136.16M13.58%-29.38M37.75%-29.25M-5.88%-41.09M32.07%-36.43M-18.78%-173.43M15.99%-34M-17.00%-46.99M
Investing cash flow
Cash flow from continuing investing activities -117.77%-8.56M62.75%30.05M-120.21%-5.67M155.52%22.64M-139.21%-94.96M33.94%48.19M-74.54%18.46M145.09%28.03M-662.57%-40.78M-163.23%-39.7M
Net PPE purchase and sale --0--083.27%-47K0.00%1K98.95%-1K--062.99%-47K35.25%-281K101.47%1K10.38%-95K
Net intangibles purchase and sale ----------0--0--5.4M---------300.00%-4M--0--0
Net business purchase and sale ----------0------------------0--------
Net investment purchase and sale -117.45%-8.56M204.16%70.05M-99.85%49K155.52%22.64M-139.10%-94.69M22.55%49.07M-68.30%23.03M119.73%32.31M-13,003.80%-40.78M-162.97%-39.6M
Net other investing changes -----784.96%-40M---5.67M--0-----------4.52M------------
Cash from discontinued investing activities
Investing cash flow -117.77%-8.56M62.75%30.05M-120.21%-5.67M155.52%22.64M-139.21%-94.96M33.94%48.19M-74.54%18.46M145.09%28.03M-662.57%-40.78M-163.23%-39.7M
Financing cash flow
Cash flow from continuing financing activities 15,248.08%146.18M3,290.23%4.24M-65.22%74.37M-86.05%2.42M-53.93%73.04M-102.57%-965K-133.33%-133K28.44%213.83M17,265.00%17.37M38,293.22%158.56M
Net common stock issuance ---------62.72%48.88M--0-------------18.93%131.11M282,860.00%14.14M----
Proceeds from stock option exercised by employees 311.14%1.4M476.85%7.03M-17.89%8.52M-15.15%5M-51.96%1.97M--341K205.26%1.22M118.25%10.38M5,508.57%5.89M890.31%4.09M
Net other financing activities 553.83%5.93M-106.00%-2.78M-76.54%16.97M3.31%-2.57M-40.79%22.2M---1.31M---1.35M--72.34M---2.66M--37.5M
Cash from discontinued financing activities
Financing cash flow 15,248.08%146.18M3,290.23%4.24M-65.22%74.37M-86.05%2.42M-53.93%73.04M-102.57%-965K-133.33%-133K28.44%213.83M17,265.00%17.37M38,293.22%158.56M
Net cash flow
Beginning cash position -51.01%53.89M-52.81%60.41M114.86%128.01M-64.99%64.92M2.18%116.01M39.46%109.99M114.86%128.01M-41.16%59.58M100.02%185.42M62.97%113.54M
Current changes in cash 1,668.92%108.54M64.37%-6.45M-198.58%-67.45M92.48%-4.32M-171.19%-51.17M-82.30%6.14M-193.85%-18.1M264.17%68.43M-73.32%-57.41M212.07%71.88M
Effect of exchange rate changes -166.37%-301K-182.56%-71K---142K---192K--77K---113K--86K--0--0--0
End cash Position 39.75%162.13M-51.01%53.89M-52.81%60.41M-52.81%60.41M-64.99%64.92M2.18%116.01M39.46%109.99M114.86%128.01M114.86%128.01M100.02%185.42M
Free cash flow -48.60%-69.08M-11.69%-40.74M23.36%-136.2M13.58%-29.38M49.33%-23.86M-8.43%-46.49M32.14%-36.48M-17.35%-177.71M16.13%-34M-16.93%-47.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg